Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

WVEWave Life Sciences, Inc.

Nasdaq · CIK 0001631574
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts276

Identity from submissions API

NameWave Life Sciences, Inc.
CIK0001631574
TickersWVE
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-949-2900
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Wave Life Sciences Ltd. (2017-07-06T04:00:00.000Z → 2026-07-30T04:00:00.000Z)
  • Wave Life Sciences LTD. (2017-07-06T04:00:00.000Z → 2026-07-30T04:00:00.000Z)
  • WAVE Life Sciences Ltd. (2017-07-06T04:00:00.000Z → 2026-07-30T04:00:00.000Z)
  • Wave Life Sciences Pte Ltd (2015-02-02T05:00:00.000Z → 2015-11-02T05:00:00.000Z)
Business address
733 CONCORD AVENUE
CAMBRIDGE
MA
02138
MA
Mailing address
733 CONCORD AVENUE
CAMBRIDGE
MA
02138
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

745 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 8-K 8-K 5.02,5.07,9.01 0001193125-26-467263 001-37627 261571346 34 283977 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001012975-26-001060 005-89180 261560441 34 11330
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003356 005-89180 261491037 34 11561
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003343 005-89180 261489731 34 10688
2026-10-27 10-Q 10-Q 0001193125-26-432714 001-37627 261487354 34 9119052 1 1
2026-10-27 8-K 8-K 2.02,9.01 0001193125-26-432690 001-37627 261487340 34 273198 1 1
2026-10-14 ARS ARS 0001193125-26-421815 001-37627 261460571 34 10263551
2026-10-14 DEF 14A DEF 14A 0001193125-26-421806 001-37627 261460548 34 3239986 1 1
2026-10-07 4 xslF345X06/form4-10082026_011038.xml 0001231919-26-001433 15313
2026-10-07 4 4 0001193125-26-417237 33730
2026-10-07 4 4 0001193125-26-417236 7397
2026-10-07 4 4 0001193125-26-417235 9264
2026-10-07 4 4 0001193125-26-417234 33151
2026-10-07 4 4 0001193125-26-417233 7395
2026-10-07 4 4 0001193125-26-417231 7468
2026-10-07 4 4 0001193125-26-417232 31877
2026-08-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002660 333-233052 261284602 33 2023
2026-08-13 4 4 0001193125-26-349963 34659
2026-08-13 4 4 0001193125-26-349962 28988
2026-08-13 4 4 0001193125-26-349961 30968
2026-08-13 4 4 0001193125-26-349960 29218
2026-08-12 144 xsl144X01/primary_doc.xml 0001950047-26-008025 001-37627 261268059 33 4999
2026-08-11 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000222 005-89180 261263911 34 21326
2026-08-11 144 xsl144X01/primary_doc.xml 0001950047-26-007963 001-37627 261263772 33 5017
2026-08-10 15-12G 15-12G 0001193125-26-340683 001-37627 261255794 34 11460
2026-08-10 POS AM POS AM 0001193125-26-340682 333-233052 261255792 33 331732
2026-08-10 POSASR POSASR 0001193125-26-340679 333-283122 261255789 33 1398655
2026-08-10 S-8 POS S-8 POS 0001193125-26-340676 333-291409 261255780 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340673 333-291408 261255774 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340670 333-283125 261255772 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340669 333-283123 261255771 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340668 333-275421 261255764 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340666 333-275420 261255761 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340665 333-268286 261255758 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340663 333-260948 261255756 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340662 333-259196 261255754 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340661 333-243515 261255753 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340660 333-243491 261255752 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340658 333-234519 261255750 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340657 333-233054 261255747 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340649 333-228308 261255741 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340642 333-221480 261255731 33 273590
2026-08-10 S-8 POS S-8 POS 0001193125-26-340640 333-208598 261255727 33 273590
2026-08-07 8-K12B 8-K12B 1.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01 0001193125-26-340430 001-37627 261255113 34 972557 1 1
2026-07-30 10-Q 10-Q 0001193125-26-324949 001-37627 261220237 34 8510851 1 1
2026-07-30 8-K 8-K 2.02,7.01,9.01 0001193125-26-324917 001-37627 261220219 34 17156526 1 1
2026-06-26 8-K 8-K 5.07 0001193125-26-284002 001-37627 261123956 34 142262 1 1
2026-05-18 8-K 8-K 7.01,8.01,9.01 0001193125-26-229076 001-37627 26994374 34 183685 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002937 005-89180 26971296 34 12787
2026-05-07 DEF 14A DEF 14A 0001193125-26-211828 001-37627 26952933 34 1403550
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001311 005-89180 26946985 34 11471
2026-05-05 UPLOAD filename1.pdf 0000000000-26-004561 001-37627 148851
2026-05-01 CORRESP filename1.htm 0001193125-26-201513 31103
2026-05-01 PRER14A PRER14A 0001193125-26-201507 001-37627 26932912 34 1354030
2026-04-30 10-K/A 10-K/A 0001193125-26-197330 001-37627 26925558 34 2709206 1 1
2026-04-30 UPLOAD filename1.pdf 0000000000-26-004427 001-37627 155349
2026-04-28 10-Q 10-Q 0001193125-26-183587 001-37627 26903178 34 5714663 1 1
2026-04-28 8-K 8-K 2.02,7.01,9.01 0001193125-26-183563 001-37627 26903154 34 17340277 1 1
2026-04-21 DEFA14A DEFA14A 0001193125-26-167145 001-37627 26880444 34 48111
2026-04-21 8-K 8-K 8.01,9.01 0001193125-26-167070 001-37627 26880217 34 178820 1 1
2026-04-17 3 3 0001193125-26-162127 28211
2026-04-17 3 3 0001193125-26-162126 29499
2026-04-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000110 005-89180 26872411 34 17432
2026-04-15 PRE 14A PRE 14A 0001193125-26-157024 001-37627 26864293 34 1352093
2026-04-15 DEFA14A DEFA14A 0001193125-26-157014 001-37627 26864260 34 184024
2026-04-15 8-K 8-K 1.01,8.01,9.01 0001193125-26-157003 001-37627 26864230 34 339937 1 1
2026-03-30 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000086 005-89180 26816324 34 16802
2026-03-30 4 xslF345X06/form4-03312026_120347.xml 0001231919-26-000297 19546
2026-03-26 4 4 0001193125-26-126276 9603
2026-03-26 8-K 8-K 7.01,8.01,9.01 0001193125-26-125092 001-37627 26794347 34 187255 1 1
2026-02-27 4 4 0001193125-26-083712 14220
2026-02-26 10-K 10-K 0001193125-26-073472 001-37627 26681749 34 17461631 1 1
2026-02-26 8-K 8-K 2.02,7.01,9.01 0001193125-26-073437 001-37627 26681733 34 16915187 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000904 005-89180 26623686 34 12934
2026-02-11 4 4 0001193125-26-047323 9164
2026-02-11 4 4 0001193125-26-047322 8967
2026-02-11 4 4 0001193125-26-047319 9040
2026-02-11 4 4 0001193125-26-047314 9332
2026-02-09 144 xsl144X01/primary_doc.xml 0001193125-26-043334 001-37627 26613244 33 5997
2026-02-09 144 xsl144X01/primary_doc.xml 0001193125-26-043330 001-37627 26613243 33 6010
2026-02-09 144 xsl144X01/primary_doc.xml 0001193125-26-043327 001-37627 26613239 33 4781
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000558 005-89180 26602079 34 11782
2026-02-02 8-K 8-K 8.01,9.01 0001193125-26-032698 001-37627 26585766 34 162416 1 1
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-009784 001-37627 26524685 34 20677137 1 1
2026-01-06 4 4 0001193125-26-005195 10996
2025-12-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000072 005-89180 251572394 34 16131
2025-12-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-020336 5728
2025-12-11 424B5 424B5 0001193125-25-314747 333-283122 251563365 33 1456859 1 1
2025-12-11 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-25-314746 001-37627 251563362 34 802623 1 1
2025-12-10 4 4 0001193125-25-314742 8433
2025-12-10 4 4 0001193125-25-314741 11264
2025-12-10 4 4 0001193125-25-314740 20631
2025-12-10 4 4 0001193125-25-314739 28684
2025-12-10 4 4 0001193125-25-314738 7326
2025-12-10 4 4 0001193125-25-314737 41011
2025-12-10 4 4 0001193125-25-314736 31016
2025-12-10 4 4 0001193125-25-314735 7359
2025-12-09 144 xsl144X01/primary_doc.xml 0001950047-25-010006 001-37627 251559386 33 5888
2025-12-08 144 xsl144X01/primary_doc.xml 0001968582-25-001177 001-37627 251557267 33 5446
2025-12-08 424B5 424B5 0001193125-25-311383 333-283122 251556856 33 1301968
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009952 001-37627 251556598 33 5125
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009945 001-37627 251556571 33 5109
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009942 001-37627 251556562 33 5363
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009936 001-37627 251556545 33 5136
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009934 001-37627 251556539 33 5892
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009930 001-37627 251556532 33 5079
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009906 001-37627 251556431 33 5702
2025-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-310595 001-37627 251554647 34 279663 1 1
2025-11-17 8-K 8-K 7.01,9.01 0001193125-25-283929 001-37627 251489325 34 17594297 1 1
2025-11-14 4 4 0001193125-25-283619 5360
2025-11-14 4 xslF345X05/form4-11142025_111155.xml 0001231919-25-000499 13095
2025-11-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000055 005-89180 251480655 34 15990
2025-11-13 144 xsl144X01/primary_doc.xml 0001950047-25-008829 001-37627 251478941 33 5038
2025-11-10 S-8 S-8 0001193125-25-273391 333-291409 251464668 33 249359 1 1
2025-11-10 S-8 S-8 0001193125-25-273384 333-291408 251464652 33 263406 1 1
2025-11-10 10-Q 10-Q 0001193125-25-273288 001-37627 251464387 34 6899728 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-273278 001-37627 251464366 34 278492 1 1
2025-10-30 8-K/A 8-K/A 7.01,8.01,9.01 0001193125-25-257298 001-37627 251431995 34 198261 1 1
2025-10-29 8-K 8-K 7.01,8.01,9.01 0001193125-25-256682 001-37627 251431143 34 196248 1 1
2025-09-24 8-K 8-K 7.01,9.01 0001193125-25-214176 001-37627 251335347 34 16578906 1 1
2025-09-03 8-K 8-K 7.01,8.01,9.01 0001193125-25-194511 001-37627 251287762 34 181001 1 1
2025-08-26 4 4 0000950170-25-111568 4862
2025-08-26 4 4 0000950170-25-111567 5428
2025-08-22 144 xsl144X01/primary_doc.xml 0001950047-25-006250 001-37627 251246823 33 5845
2025-08-22 144 xsl144X01/primary_doc.xml 0001950047-25-006240 001-37627 251246797 33 5786
2025-08-19 4 4 0000950170-25-110287 8440
2025-08-15 144 xsl144X01/primary_doc.xml 0001950047-25-005939 001-37627 251225467 33 5869
2025-08-13 4 xslF345X05/form4-08142025_120830.xml 0001415889-25-021689 14992
2025-08-13 4 4 0000950170-25-108291 7164
2025-08-13 4 4 0000950170-25-108290 7389
2025-08-13 4 4 0000950170-25-108289 7343
2025-08-13 4 4 0000950170-25-108288 7304
2025-08-13 4 4 0000950170-25-108287 9386
2025-08-13 4 4 0000950170-25-108286 7286
2025-08-13 4 4 0000950170-25-108285 7316
2025-08-13 144 xsl144X01/primary_doc.xml 0001968582-25-000732 001-37627 251211364 33 4733
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003507 005-89180 251204576 34 12668
2025-08-11 8-K 8-K 5.02,5.07,9.01 0001193125-25-178083 001-37627 251203041 34 295162 1 1
2025-08-07 4 4 0000950170-25-105353 4972
2025-08-07 4 4 0000950170-25-105352 4922
2025-08-05 8-K 8-K 7.01,9.01 0001193125-25-173053 001-37627 251182860 34 15148638 1 1
2025-07-30 10-Q 10-Q 0000950170-25-099884 001-37627 251163991 34 6496401 1 1
2025-07-30 8-K 8-K 2.02,9.01 0001193125-25-168644 001-37627 251163976 34 271425 1 1
2025-06-23 ARS ARS 0001193125-25-144681 001-37627 251065334 34 13568133
2025-06-23 DEF 14A DEF 14A 0001193125-25-144678 001-37627 251065316 34 3567566 1 1
2025-06-13 4 4 0000950170-25-086466 5387
2025-06-13 144 xsl144X01/primary_doc.xml 0001950047-25-004284 001-37627 251047295 33 5118
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002246 005-89180 25932868 34 12698
2025-05-08 10-Q 10-Q 0000950170-25-066404 001-37627 25923941 34 5881505 1 1
2025-05-08 8-K 8-K 2.02,7.01,9.01 0001193125-25-115489 001-37627 25923921 34 14439076 1 1
2025-04-29 10-K/A 10-K/A 0000950170-25-060301 001-37627 25888946 34 2449901 1 1
2025-03-26 8-K 8-K 7.01,8.01,9.01 0001193125-25-063184 001-37627 25770193 34 205534 1 1
2025-03-21 4 4 0000950170-25-043440 9003
2025-03-20 144 xsl144X01/primary_doc.xml 0001968582-25-000218 001-37627 25756410 33 4742
2025-03-07 4 4 0000950170-25-035835 11221
2025-03-07 4 4 0000950170-25-035834 10248
2025-03-07 144 xsl144X01/primary_doc.xml 0001950047-25-001675 001-37627 25721185 33 5195
2025-03-05 4 4 0000950170-25-033838 8999
2025-03-04 10-K 10-K 0000950170-25-031322 001-37627 25701591 34 27680239 1 1
2025-03-04 8-K 8-K 2.02,7.01,9.01 0001193125-25-044876 001-37627 25701579 34 3729842 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021210 005-89180 25628899 34 12104
2025-02-06 4 4 0000950170-25-015682 7369
2025-02-06 4 4 0000950170-25-015681 7176
2025-02-06 4 4 0000950170-25-015680 7247
2025-02-06 4 4 0000950170-25-015679 7267
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001460 005-89180 25594528 34 12382
2025-01-24 4 4 0000950170-25-008909 7186
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-005233 001-37627 25525849 34 11082919 1 1
2024-11-27 4 4 0000950170-24-131691 8508
2024-11-25 144 xsl144X01/primary_doc.xml 0001950047-24-009108 001-37627 241496979 33 6718
2024-11-20 8-K 8-K 7.01,9.01 0001193125-24-262067 001-37627 241478119 34 12809134 1 1
2024-11-15 4 4 0000950170-24-127740 5433
2024-11-15 144 xsl144X01/primary_doc.xml 0001950047-24-008615 001-37627 241468099 33 6723
2024-11-13 4 4 0000950170-24-126622 8588
2024-11-12 SC 13G/A WAVE LIFE SCIENCES LTD. 0000902664-24-006436 005-89180 241448913 34 61681
2024-11-12 SC 13G/A p24-3046sc13ga.htm 0000902664-24-006408 005-89180 241444229 34 71391
2024-11-12 S-8 S-8 0001193125-24-255192 333-283125 241443596 33 138330
2024-11-12 S-8 S-8 0001193125-24-255187 333-283123 241443535 33 155453
2024-11-12 S-3ASR S-3ASR 0001193125-24-255180 333-283122 241443470 33 1688761
2024-11-12 10-Q 10-Q 0000950170-24-124595 001-37627 241443360 34 5992485 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001193125-24-255157 001-37627 241443344 34 285214 1 1
2024-11-08 144 xsl144X01/primary_doc.xml 0001950047-24-008284 001-37627 241440740 33 8225
2024-11-08 SC 13G sg9999014716_110824.txt 0002012383-24-003590 005-89180 241439735 34 14089
2024-10-30 8-K 8-K 7.01,8.01,9.01 0001193125-24-247660 001-37627 241411431 34 183501 1 1
2024-10-18 4 4 0000950170-24-115726 19937
2024-10-18 4 4 0000950170-24-115725 4905
2024-10-18 SC 13G sg9999014716_101824.txt 0002012383-24-000564 005-89180 241380521 34 14077
2024-10-16 144 xsl144X01/primary_doc.xml 0001950047-24-007765 001-37627 241374845 33 9264
2024-10-16 144 xsl144X01/primary_doc.xml 0001950047-24-007758 001-37627 241374765 33 6552
2024-10-16 8-K 8-K 7.01,8.01,9.01 0001193125-24-237869 001-37627 241373363 34 174782 1 1
2024-10-15 8-K 8-K 7.01,8.01 0001193125-24-237665 001-37627 241372672 34 148157 1 1
2024-10-11 4 4 0000950170-24-114422 6900
2024-10-01 4 WVE - CHANGE IN BENEFICIAL OWNERSHIP 0001999371-24-012789 5664
2024-10-01 SC 13D/A SC 13D/A 0001104659-24-105033 005-89180 241344620 34 89621
2024-10-01 8-K 8-K 7.01,9.01 0001193125-24-229513 001-37627 241341322 34 12426170 1 1
2024-09-27 4 4 0000950170-24-110141 5103
2024-09-27 424B5 424B5 0001193125-24-227080 333-263251 241330379 33 1267732
2024-09-26 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-24-227053 001-37627 241329817 34 805775 1 1
2024-09-25 144 xsl144X01/primary_doc.xml 0000950170-24-109458 001-37627 241326003 33 4821
2024-09-24 424B5 424B5 0001193125-24-224898 333-263251 241320873 33 1266294
2024-09-24 424B3 424B3 0001193125-24-224894 333-263251 241320859 33 55351
2024-09-24 8-K 8-K 7.01,8.01,9.01 0001193125-24-224116 001-37627 241317550 34 195276 1 1
2024-08-23 4 4 0000950170-24-100274 5430
2024-08-21 144 xsl144X01/primary_doc.xml 0001950047-24-006345 001-37627 241229014 33 5786
2024-08-14 4 xslF345X05/form4-08142024_100845.xml 0001415889-24-021318 14998
2024-08-14 4 4 0000950170-24-097290 7292
2024-08-14 4 4 0000950170-24-097289 7300
2024-08-14 4 4 0000950170-24-097287 7283
2024-08-14 4 4 0000950170-24-097286 7262
2024-08-14 4 4 0000950170-24-097285 7321
2024-08-14 4 4 0000950170-24-097284 7402
2024-08-14 4 4 0000950170-24-097283 7348
2024-08-12 8-K 8-K 5.02,5.07,9.01 0001193125-24-199020 001-37627 241198063 34 302416 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093341 001-37627 241186118 34 4909251 1 1
2024-08-08 8-K 8-K 2.02,7.01,9.01 0001193125-24-196489 001-37627 241186083 34 3808056 1 1
2024-07-24 4 4 0000950170-24-086173 7292
2024-06-25 8-K 8-K 7.01,8.01,9.01 0001193125-24-167481 001-37627 241066166 34 192958 1 1
2024-06-21 ARS ARS 0001193125-24-165723 001-37627 241060784 34 11288310
2024-06-21 DEF 14A DEF 14A 0001193125-24-165712 001-37627 241060748 34 2216790
2024-05-10 10-Q 10-Q 0000950170-24-057457 001-37627 24932895 34 4395034 1 1
2024-05-09 8-K 8-K 2.02,7.01,9.01 0001193125-24-134769 001-37627 24928607 34 13863052 1 1
2024-04-29 10-K/A 10-K/A 0001193125-24-122488 001-37627 24891497 34 842823 1 1
2024-04-05 4 4 0000950170-24-042381 5633
2024-04-03 144 xsl144X01/primary_doc.xml 0001950047-24-002905 001-37627 24818652 33 7466
2024-03-06 10-K 10-K 0000950170-24-026876 001-37627 24724393 34 16868326 1 1
2024-03-06 8-K 8-K 2.02,7.01,9.01 0001193125-24-060001 001-37627 24724383 34 4234771 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036535 005-89180 24640181 34 79221
2024-02-14 SC 13G/A 683 CAPITAL MANAGEMENT, LLC 0001085146-24-001431 005-89180 24637564 34 45286
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-033095 005-89180 24623165 34 49527
2024-02-12 SC 13G/A WAVE LIFE SCIENCES LTD. 0000902664-24-001424 005-89180 24620092 34 63302
2024-02-07 4 4 0000950170-24-012401 5607
2024-02-07 4 4 0000950170-24-012395 5534
2024-02-07 4 4 0000950170-24-012394 5535
2024-02-07 4 4 0000950170-24-012392 5626
2024-02-07 SC 13G/A WAVE LIFE SCIENCES LTD. 0000902664-24-001195 005-89180 24602249 34 98805
2024-02-06 SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-001596 005-89180 24601131 34 28310
2024-01-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-24-001192 5704
2024-01-17 4/A OWNERSHIP DOCUMENT 0001104659-24-004581 11687
2024-01-08 8-K 8-K 7.01,9.01 0001193125-24-003944 001-37627 24518447 34 12872202 1 1
2024-01-04 8-K 8-K 8.01 0001193125-24-002437 001-37627 24511860 34 142900 1 1
2023-12-15 8-K 8-K 7.01,9.01 0001193125-23-296047 001-37627 231488895 34 4476589 1 1
2023-12-13 4 OWNERSHIP DOCUMENT 0001104659-23-125724 11193
2023-12-08 424B5 424B5 0001193125-23-291137 333-263251 231473862 33 1090560
2023-12-08 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-23-290972 001-37627 231473806 34 575490 1 1
2023-12-06 424B5 424B5 0001193125-23-289905 333-263251 231469733 33 1125463
2023-11-09 8-K 8-K 7.01,9.01 0001193125-23-274537 001-37627 231392984 34 5668813 1 1
2023-11-09 S-8 FORM S-8 0001193125-23-274107 333-275421 231390259 33 133665
2023-11-09 S-8 FORM S-8 0001193125-23-274106 333-275420 231390257 33 131551
2023-11-09 10-Q 10-Q 0000950170-23-061544 001-37627 231390119 34 6173251 1 1
2023-11-09 8-K FORM 8-K 2.02,9.01 0001193125-23-274068 001-37627 231390096 34 278182 1 1
2023-10-02 8-K 8-K 7.01,9.01 0001193125-23-248077 001-37627 231297731 34 17374754 1 1
2023-09-28 8-K 8-K 7.01,8.01,9.01 0001193125-23-245724 001-37627 231290343 34 193559 1 1
2023-09-05 8-K 8-K 7.01,9.01 0001193125-23-228527 001-37627 231235740 34 10311121 1 1
2023-08-23 4 FORM 4 SUBMISSION 0000899243-23-018361 5774
2023-08-23 144 xsl144X01/primary_doc.xml 0001950047-23-003409 001-37627 231198163 33 7289
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017916 5684
2023-08-09 4 OWNERSHIP DOCUMENT 0001104659-23-089416 12176
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017915 5731
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017914 5694
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017913 5553
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017912 5679
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017910 5705
2023-08-09 4 FORM 4 SUBMISSION 0000899243-23-017911 5667
2023-08-07 8-K 8-K 5.02,5.07,9.01 0001193125-23-205066 001-37627 231148340 34 353844 1 1
2023-08-03 10-Q 10-Q 0000950170-23-037601 001-37627 231138136 34 5561896 1 1
2023-08-03 8-K 8-K 2.02,7.01,9.01 0001193125-23-202288 001-37627 231138100 34 10423010 1 1
2023-06-26 DEF 14A DEF 14A 0001193125-23-175031 001-37627 231042320 34 1669350
2023-05-23 8-K 8-K 7.01,8.01,9.01 0001193125-23-151113 001-37627 23946530 34 10429447 1 1
2023-05-05 10-K/A 10-K/A 0001193125-23-137092 001-37627 23893832 34 813151 1 1
2023-05-03 10-Q 10-Q 0000950170-23-016888 001-37627 23881723 34 4732879 1 1
2023-05-03 8-K 8-K 2.02,7.01,9.01 0001193125-23-133192 001-37627 23881708 34 11088770 1 1
2023-04-28 10-K/A 10-K/A 0001193125-23-127621 001-37627 23868276 34 876856 1 1
2023-03-23 10-K 10-K 0000950170-23-009319 001-37627 23754473 34 23241473 1 1
2023-03-22 8-K 8-K 2.02,9.01 0001193125-23-076278 001-37627 23751431 34 279403 1 1
2023-03-10 8-K 8-K 7.01 0001193125-23-067714 001-37627 23724546 34 145863 1 1
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005565 8496
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005564 8180
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005563 8229
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005562 8427
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039084 005-89180 23629129 34 51568
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0001013594-23-000218 005-89180 23627006 34 71029
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038004 005-89180 23625072 34 78575
2023-02-10 SC 13G/A WAVE LIFE SCIENCES LTD. 0000902664-23-001463 005-89180 23611764 34 49006
2023-01-30 SC 13G SCHEDULE 13G 0001839882-23-002074 005-89180 23568352 34 27450
2023-01-30 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP 0001839882-23-002069 4560
2023-01-30 8-K 8-K 1.01,8.01 0001193125-23-018358 001-37627 23565293 34 144138 1 1
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004175 001-37627 23516663 34 21750734 1 1
2022-12-22 SC 13G WAVE LIFE SCIENCES LTD. 0000902664-22-005274 005-89180 221482295 34 107467
2022-12-19 8-K/A 8-K/A 7.01,8.01,9.01 0001193125-22-308032 001-37627 221469907 34 193057 1 1
2022-12-19 8-K 8-K 7.01,8.01,9.01 0001193125-22-307889 001-37627 221469627 34 186702 1 1
2022-12-13 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-22-303251 001-37627 221458558 34 1779355 1 1
2022-12-08 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-22-004240 005-89180 221451810 34 27711
2022-11-15 8-K 8-K 7.01,9.01 0001193125-22-285306 001-37627 221389522 34 20204381 1 1
2022-11-10 S-8 S-8 0001193125-22-281997 333-268286 221375084 33 139326
2022-11-10 10-Q 10-Q 0000950170-22-024171 001-37627 221374997 34 6397325 1 1
2022-11-10 8-K 8-K 2.02,9.01 0001193125-22-281960 001-37627 221374965 34 279100 1 1
2022-10-28 4 FORM 4 SUBMISSION 0000899243-22-034493 5748
2022-10-04 8-K 8-K 7.01,9.01 0001193125-22-257214 001-37627 221289731 34 20263496 1 1
2022-09-28 8-K 8-K 7.01,9.01 0001193125-22-253068 001-37627 221274749 34 187419 1 1
2022-09-26 8-K 8-K 5.02 0001193125-22-251264 001-37627 221265861 34 143791 1 1
2022-09-20 8-K 8-K 7.01,8.01,9.01 0001193125-22-247417 001-37627 221252078 34 196646 1 1
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029100 5648
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029099 5636
2022-08-17 4 OWNERSHIP DOCUMENT 0001104659-22-092280 12062
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029098 5674
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029097 5663
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029096 5692
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029095 5522
2022-08-17 4 FORM 4 SUBMISSION 0000899243-22-029094 5653
2022-08-17 8-K 8-K 7.01,9.01 0001193125-22-223295 001-37627 221174540 34 17840066 1 1
2022-08-15 8-K 8-K 5.02,5.07,9.01 0001193125-22-221350 001-37627 221167235 34 301063 1 1
2022-08-12 SC 13D/A SCHEDULE 13D AMENDMENT NO. 5 0001193125-22-219226 005-89180 221157754 34 343160
2022-08-11 10-Q 10-Q 0000950170-22-016653 001-37627 221153733 34 5762843 1 1
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-217982 001-37627 221153716 34 282738 1 1
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026928 5574
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026927 5621
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026926 5574
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026922 5616
2022-07-27 4 FORM 4 SUBMISSION 0000899243-22-026918 5640
2022-07-20 SC 13D/A SC 13D/A 0001193125-22-197364 005-89180 221092712 34 47293
2022-06-29 DEF 14A DEF 14A 0001193125-22-185092 001-37627 221055056 34 2075203
2022-06-21 SC 13D/A SC 13D/A 0001104659-22-072993 005-89180 221028600 34 91472
2022-06-21 4 OWNERSHIP DOCUMENT 0001104659-22-072990 14003
2022-06-14 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-22-173529 001-37627 221013578 34 652558 1 1
2022-06-14 424B5 424B5 0001193125-22-173526 333-263251 221013573 33 1278475
2022-05-26 SC 13G wave13g-051622.htm 0001013594-22-000456 005-89180 22970837 34 83272
2022-05-12 10-Q 10-Q 0000950170-22-009469 001-37627 22915746 34 5020278 1 1
2022-05-12 8-K 8-K 2.02,7.01,9.01 0001193125-22-148091 001-37627 22915743 34 20453675 1 1
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017136 7936
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017135 7867
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017133 7867
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017130 7912
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017124 7917
2022-05-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-04 16:00:00 9999999995-22-001308 333-263251 22893792 33 2005
2022-05-02 CORRESP filename1.htm 0001193125-22-136918 7415
2022-04-28 10-K/A 10-K/A 0001193125-22-127544 001-37627 22866569 34 998023 1 1
2022-04-04 8-K 8-K 7.01,8.01,9.01 0001193125-22-094408 001-37627 22800379 34 195217 1 1
2022-03-07 UPLOAD filename1.pdf 0000000000-22-002504 40488
2022-03-03 8-K 8-K 1.01,9.01 0001193125-22-064309 001-37627 22708577 34 166374 1 1
2022-03-03 S-3 S-3 0001193125-22-063690 333-263251 22706809 33 1682778
2022-03-03 10-K 10-K 0001564590-22-008414 001-37627 22706765 34 16239305 1 1
2022-03-03 8-K 8-K 2.02,7.01,9.01 0001193125-22-063644 001-37627 22706758 34 22058697 1 1
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007066 6015
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007065 5738
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007064 6035
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007062 5761
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007059 5805
2022-02-14 SC 13G SC 13G 0001193125-22-041305 005-89180 22630188 34 80274
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-021709 005-89180 22625564 34 48570
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037225 005-89180 22621932 34 50420
2022-02-11 SC 13G/A e621308_sc13ga-wave.htm 0001193805-22-000258 005-89180 22621241 34 98619
2022-02-11 SC 13G/A SC 13G/A WAVE LIFE SCIENCE LTD 0000078003-22-000008 005-89180 22620800 34 70511
2022-02-10 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-22-000743 005-89180 22612518 34 28100
2022-01-10 8-K 8-K 7.01,9.01 0001193125-22-005027 001-37627 22519630 34 15064653 1 1
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000670 5646
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000668 5688
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000666 5674
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000663 5693
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000660 5664
2021-12-10 SC 13G/A sg9999014716_121021.txt 0000834237-21-009354 005-89180 211484139 34 12593
2021-11-12 SC 13D/A SC 13D/A 0001104659-21-138120 005-89180 211404056 34 94937
2021-11-10 S-8 S-8 0001193125-21-325364 333-260948 211394553 33 147129
2021-11-10 10-Q 10-Q 0001564590-21-055927 001-37627 211394442 34 6070224 1 1
2021-11-10 8-K 8-K 2.02,7.01,9.01 0001193125-21-325280 001-37627 211394428 34 25587770 1 1
2021-10-29 SC 13G SC 13G 0000905718-21-001406 005-89180 211361626 34 46278
2021-10-18 8-K 8-K 1.01,7.01,9.01 0001193125-21-301165 001-37627 211328832 34 175893 1 1
2021-09-28 8-K 8-K 7.01,9.01 0001193125-21-285507 001-37627 211286924 34 15928117 1 1
2021-09-10 8-K 8-K 7.01,9.01 0001193125-21-269447 001-37627 211245859 34 19517502 1 1
2021-08-31 S-8 S-8 0001193125-21-262042 333-259196 211227003 33 134403
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033531 5663
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033528 5697
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033527 5715
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033525 5671
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033522 5522
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033520 5659
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033519 5653
2021-08-18 4 OWNERSHIP DOCUMENT 0001104659-21-107410 12018
2021-08-18 SC 13D/A AMENDMENT NO. 3 0001104659-21-107408 005-89180 211187599 34 99525
2021-08-16 8-K 8-K 5.07 0001193125-21-247771 001-37627 211178593 34 173906 1 1
2021-08-05 10-Q 10-Q 0001564590-21-041192 001-37627 211146377 34 4194086 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001193125-21-236998 001-37627 211146353 34 278116 1 1
2021-06-28 DEF 14A DEF 14A 0001193125-21-202165 001-37627 211054431 34 1309064
2021-06-02 8-K 8-K 9.01 0001193125-21-180083 001-37627 21990295 34 20343277 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027223 001-37627 21917244 34 3428002 1 1
2021-05-13 8-K 8-K 2.02,7.01,9.01 0001193125-21-159836 001-37627 21917227 34 19160654 1 1
2021-04-30 10-K/A 10-K/A 0001193125-21-145367 001-37627 21879104 34 939083 1 1
2021-04-09 SC 13G e620460_sc13g-wls.htm 0001193805-21-000469 005-89180 21817267 34 99813
2021-04-05 4 OWNERSHIP DOCUMENT 0001104659-21-046610 13599
2021-04-01 8-K 8-K 7.01,9.01 0001193125-21-103324 001-37627 21796136 34 18757128 1 1
2021-03-29 8-K 8-K 7.01,8.01,9.01 0001193125-21-098276 001-37627 21781791 34 206613 1 1
2021-03-24 4 FORM 4 SUBMISSION 0000899243-21-013331 7155
2021-03-04 10-K 10-K 0001564590-21-010718 001-37627 21712556 34 19571778 1 1
2021-03-04 8-K 8-K 2.02,7.01,9.01 0001193125-21-068443 001-37627 21712546 34 19554628 1 1
2021-02-18 4 FORM 4 SUBMISSION 0000899243-21-007209 9751
2021-02-18 4 FORM 4 SUBMISSION 0000899243-21-007207 9709
2021-02-18 4 FORM 4 SUBMISSION 0000899243-21-007206 9746
2021-02-18 4 FORM 4 SUBMISSION 0000899243-21-007203 9922
2021-02-18 4 FORM 4 SUBMISSION 0000899243-21-007201 9904
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-023954 005-89180 21638345 34 74075
2021-02-16 SC 13G SCHEDULE 13G 0001104659-21-023294 005-89180 21633939 34 63761

Latest XBRL company facts

One latest value per concept from companyfacts (276 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 197.23M 2026-10-21 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
dei EntityPublicFloat Entity Public Float USD 851.01M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197330
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.82M 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.21M 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 66.11 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 18.59M 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
ecd PeoTotalCompAmt PeoTotalCompAmt USD 12.28M 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 216.01 2025-01-01 2025-12-31 DEF 14A 2026-10-14 0001193125-26-421806
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 19.30M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 12.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AccountsReceivableNetNoncurrent Accounts Receivable, after Allowance for Credit Loss, Noncurrent USD 30.00M 2019-12-31 2020 FY 10-K 2021-03-04 0001564590-21-010718
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 21.98M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.37M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.28M 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 33,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 51.39M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -565,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.89B 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 46.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 30.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap Assets Assets USD 507.93M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AssetsCurrent Assets, Current USD 458.63M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AssetsNoncurrent Assets, Noncurrent USD 49.30M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2025-12-31 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 309,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 234.01M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 233.70M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1.85M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028757
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 16,000 2017-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 268,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 16,000 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 197.31M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -7.79M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 431.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 114.10M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 201.13M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -404.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-07-30 0001193125-26-324949
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 197.21M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 197.21M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap CommonStockValue Common Stock, Value, Issued USD 197,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -157.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 9.11M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 12.34M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 2.02M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD -352,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 9.60M 2014-02-01 2014-02-28 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1.52M 2014-02-01 2014-02-28 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-07-30 0001193125-26-324949
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 908,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 115,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 5.13M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 1.27M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 5.82M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 5.45M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 329.75M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 449,000 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004649
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 214,000 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 560,000 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 243.03M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 24.46M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 1.29M 2014-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 4.28M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 326.69M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 25,000 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682053
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 3.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 4,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap Depreciation Depreciation USD 2.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.15M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap DividendsReceivable Dividends Receivable USD 30,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038620
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.62 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009469
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 43,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap EffectOfExchangeRateOnCashContinuingOperations Effect of Exchange Rate on Cash, Continuing Operations USD 403,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.91M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 67,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023225
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 310,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009469
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009469
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 268,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028710
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -12,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031322
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 72.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-12-17 0001193125-15-406371
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -157.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 438,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028757
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 18.69M 2020-03-31 2020 Q1 10-Q 2020-05-11 0001564590-20-023860
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -3.10M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-06 0001564590-19-029396
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 10.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -30.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.42M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 7.47M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040431
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.42M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040431
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 3.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 9,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 950,168 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124595
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 86,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -16,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-010718
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 37,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap InvestmentIncomeDividend Investment Income, Dividend USD 584,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-010718
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 14.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 10.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 596,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap LeaseCost Lease, Cost USD 10.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap LeaseIncentivePayableCurrent Lease Incentive, Payable, Current USD 1.16M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 19.46M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 886,000 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 9.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 886,000 2023-12-31 2023 FY 10-K 2024-03-06 0000950170-24-026876
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 886,000 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031322
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 886,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 8.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.44M 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040431
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.69M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap Liabilities Liabilities USD 105.99M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 507.93M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 319,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028710
us-gaap LiabilitiesCurrent Liabilities, Current USD 54.76M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 51.23M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap MarketableSecurities Marketable Securities USD 233.70M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 233.43M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 263,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -309,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.54M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -234.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1.16M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -173.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -32.43M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -157.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -204.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 13.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-07-30 0001193125-26-324949
us-gaap OperatingExpenses Operating Expenses USD 224.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -171.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 4.50M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 17.77M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.38M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 38.90M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OperatingLeasePayments Operating Lease, Payments USD 9.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 38.09M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 49.91M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 5.67M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.24M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6.20M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.02M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 5.85M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 20.93M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 4.90M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.093 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 54.70M 2023-12-31 2023 FY 10-K 2024-03-06 0000950170-24-026876
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 959,000 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004649
us-gaap OtherAssets Other Assets USD 196,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124595
us-gaap OtherAssetsCurrent Other Assets, Current USD 4.33M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 73,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038620
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 895,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -393,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap OtherIncome Other Income USD 155,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 156,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 190,000 2022-12-31 2023 FY 10-K 2024-03-06 0000950170-24-026876
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -599,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124595
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 4.30M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028757
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 1.07M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap PaymentsForRestructuring Payments for Restructuring USD 3.10M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052211
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 2.73M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028757
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 15,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 236.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 75.04M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031322
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 10 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 10,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 30.00M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 21.25M 2019-09-30 2019 Q3 10-Q 2019-11-05 0001564590-19-040431
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 11.56M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 101.44M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 62.53M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 89.30M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273288
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 323.20M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 6.17M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 3.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 75.04M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031322
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 106,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031322
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 938,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -157.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 56.93M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 6.24M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-07-30 0001193125-26-324949
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 16,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 2.50M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 152.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 3.81M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 300,000 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052211
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.22 2020-02-06 2020 Q3 10-Q 2020-11-09 0001564590-20-052211
us-gaap RestructuringCharges Restructuring Charges USD 3.40M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052211
us-gaap RestructuringReserve Restructuring Reserve USD 580,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038620
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD -20,000 2020-04-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038620
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.48B 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 53.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap Revenues Revenues USD 1.42M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012539
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 30.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4.68 2022-12-13 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001193125-16-523890
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.14M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001193125-16-682053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 50,000 2020-05-01 2020-05-31 2020 Q2 10-Q 2020-08-10 0001564590-20-038620
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 3.03M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 116.54M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 10.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.7 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 728,202 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 213.26M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 24.37M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.02 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.34 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 9.7 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 10.37 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ShortTermInvestments Short-term Investments USD 25.04M 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024171
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 401.94M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 10.68M 2022-12-13 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 3.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 62.53M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 7.87M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 345,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 330.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 10.29M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 88,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap StraightLineRentAdjustments Straight Line Rent Adjustments USD 973,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-007972
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 21.37M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 2.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005308
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001564590-17-004649
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 430,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005671
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 575,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009319
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 54.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073472
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 202.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 60.52M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009469
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 202.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001193125-26-432714

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →